Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Apyx Medical Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of APYX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders49145−3
Shares13.1M495.7K12.8M+206.0K (+1.6%)
Value$17.5M$664.2K$15.9M−$1.00M (−5.9%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Apyx Medical Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to APYX in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.496,816$616.1K0.00%
HB Wealth Management, LLC50,000$62.0K0.00%
Two Sigma Securities, LLC13,727$17.0K0.00%
Northwestern Mutual Wealth Management Co103$1280.00%

Sold out (7)

Institutions that held Apyx Medical Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of APYX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
RPg Family Wealth Advisory, LLC75,250$100.8K
Wolverine Trading, LLC16,433$22.0K
Charles Schwab Investment Management Inc16,288$21.8K
Advisor Group Holdings, Inc.6,200$8.31K
Rhumbline Advisers1,284$1.72K
Qube Research & Technologies Ltd285$382
GWM Advisors LLC75$101

Not filed for Q3 2024 yet (1)

Institutions that held Apyx Medical Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APYX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.495,685$664.2K